Prendio-BioProcure has launched GenAI automation and analytics to optimize biotech procurement, cutting costs, and reducing manual tasks.
Prendio-BioProcure, a biotech procurement solutions provider, has integrated GenAI and automation to help life sciences companies streamline operations. The new AI-powered CRO Discovery Tool eliminates the time-consuming manual search for contract research organizations (CROs) by leveraging a dataset from 500+ biotech clients and $3B in CRO work to provide instant, data-backed recommendations. This ensures companies can find specialized partners quickly, accelerating preclinical and clinical research.
The AI-driven procurement system further enhances efficiency with OCR-based invoice matching, reducing errors by 95%, and a real-time PO analytics dashboard for data-driven spending decisions. The integrated supplier spend management system strengthens financial controls, helping biotech firms extend their financial runway. By eliminating administrative burdens, scientists can focus on innovation rather than procurement challenges.
“Biotech companies should be advancing science, not struggling with procurement,” said CEO Eric Meizlish. “With GenAI, we simplify workflows and maximize financial efficiency.” The AI-enhanced platform enables faster decision-making, better supplier intelligence, and cost savings, reinforcing Prendio-BioProcure’s commitment to transforming biotech procurement with cutting-edge technology.